DEMS:LSE:LSE-WisdomTree Emerging Markets Equity Income UCITS ETF - Acc GBP (GBX)

ETF | Others |

Last Closing

USD 2002.25

Change

-7.50 (-0.37)%

Market Cap

N/A

Volume

490.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+0.60 (+0.35%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.44%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.24 (+1.36%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-1.62 (-1.60%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.35 (+1.85%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.45 (+1.49%)

USD 259.48B
0QZO:LSE 0QZO

+1.10 (+1.30%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+0.80 (+0.59%)

USD 202.26B
0R24:LSE Intel Corp.

+0.92 (+4.93%)

USD 196.14B

ETFs Containing DEMS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.27% 45% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.27% 44% F 48% F
Trailing 12 Months  
Capital Gain -0.50% 42% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.50% 39% F 48% F
Trailing 5 Years  
Capital Gain 55.15% 58% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.15% 55% F 64% D
Average Annual (5 Year Horizon)  
Capital Gain 9.51% 63% D 67% D+
Dividend Return 9.51% 62% D 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.72% 75% C 87% B+
Risk Adjusted Return 123.27% 97% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike